{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T04:51:41Z","timestamp":1771563101020,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Tehran University of Medical Sciences"},{"name":"Shefa Neuroscience Research Center"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.jneuroim.2012.10.015","type":"journal-article","created":{"date-parts":[[2012,11,20]],"date-time":"2012-11-20T06:46:29Z","timestamp":1353393989000},"page":"39-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Methadone diminishes neuroinflammation and disease severity in EAE through modulating T cell function"],"prefix":"10.1016","volume":"255","author":[{"given":"Laya","family":"Kafami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ifa","family":"Etesami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mina","family":"Felfeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neda","family":"Enayati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roya","family":"Ghiaghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atefeh","family":"Aminian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmadreza","family":"Dehpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2012.10.015_bb0005","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.taap.2008.06.020","article-title":"Methadone ameliorates multiple-low-dose streptozotocin-induced type 1 diabetes in mice","volume":"232","author":"Amirshahrokhi","year":"2008","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.jneuroim.2012.10.015_bb0010","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.biopha.2006.06.015","article-title":"Pain management: is opioid immunosuppression a clinical problem?","volume":"60","author":"Budd","year":"2006","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jneuroim.2012.10.015_bb0015","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0165-5728(97)00219-1","article-title":"Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations","volume":"83","author":"Eisenstein","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2012.10.015_bb0020","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0162-3109(00)00198-3","article-title":"Differential effects of buprenorphine and morphine on immune and neuroendocrine functions following acute administration in the rat mesencephalon periaqueductal gray","volume":"48","author":"Gomez-Flores","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.jneuroim.2012.10.015_bb0025","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0022-3565(24)37665-7","article-title":"Alterations of immune functions in heroin addicts and heroin withdrawal subjects","volume":"286","author":"Govitrapong","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jneuroim.2012.10.015_bb0030","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00019052-200206000-00001","article-title":"Pathogenesis of multiple sclerosis: an update on immunology","volume":"15","author":"Hemmer","year":"2002","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jneuroim.2012.10.015_bb0035","first-page":"47","article-title":"Intermittent feeding attenuates clinical course of experimental autoimmune encephalomyelitis in C57BL\/6 mice","volume":"2","author":"Kafami","year":"2010","journal-title":"Avicenna J. Med. Biotechnol."},{"key":"10.1016\/j.jneuroim.2012.10.015_bb0040","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20041257","article-title":"IL-23 drives a pathogenic T cell population that induces autoimmune inflammation","volume":"201","author":"Langrish","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2012.10.015_bb0045","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1086\/338011","article-title":"Methadone enhances human immunodeficiency virus infection of human immune cells","volume":"185","author":"Li","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jneuroim.2012.10.015_bb0050","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0376-8716(00)00181-2","article-title":"Opioids, opioid receptors, and the immune response","volume":"62","author":"McCarthy","year":"2001","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.jneuroim.2012.10.015_bb0055","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/ni1507","article-title":"Multiple sclerosis: a complicated picture of autoimmunity","volume":"8","author":"McFarland","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2012.10.015_bb0060","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00415-008-6003-0","article-title":"Animal models of multiple sclerosis for the development and validation of novel therapies \u2014 potential and limitations","volume":"255","author":"Mix","year":"2008","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2012.10.015_bb0065","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature05969","article-title":"Essential autocrine regulation by IL-21 in the generation of inflammatory T cells","volume":"448","author":"Nurieva","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2012.10.015_bb0070","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0165-5728(97)00216-6","article-title":"Opiates and infection","volume":"83","author":"Risdahl","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2012.10.015_bb0075","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1067\/msy.2001.116033","article-title":"Morphine directs T cells toward Th2 differentiation","volume":"130","author":"Roy","year":"2001","journal-title":"Surgery"},{"key":"10.1016\/j.jneuroim.2012.10.015_bb0080","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jneuroim.2003.10.016","article-title":"Chronic morphine treatment differentiates T helper cells to Th2 effector cells by modulating transcription factors GATA 3 and T-bet","volume":"147","author":"Roy","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2012.10.015_bb0085","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1191\/0269216306pm1124oa","article-title":"Opioids and the immune system","volume":"20","author":"Sacerdote","year":"2006","journal-title":"Palliat. Med."},{"key":"10.1016\/j.jneuroim.2012.10.015_bb0090","first-page":"98","article-title":"Opioid receptor expression and intracellular signaling by cells involved in host defense and immunity","volume":"521","author":"Sharp","year":"2003","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jneuroim.2012.10.015_bb0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bbi.2005.02.002","article-title":"Multiple opioid receptors on immune cells modulate intracellular signaling","volume":"20","author":"Sharp","year":"2006","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jneuroim.2012.10.015_bb0100","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.it.2005.08.014","article-title":"Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis","volume":"26","author":"Steinman","year":"2005","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jneuroim.2012.10.015_bb0105","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1038\/nprot.2006.285","article-title":"Active induction of experimental allergic encephalomyelitis","volume":"1","author":"Stromnes","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jneuroim.2012.10.015_bb0110","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.neuint.2009.10.013","article-title":"Alteration of lymphocyte opioid receptors in methadone maintenance subjects","volume":"56","author":"Toskulkao","year":"2010","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.jneuroim.2012.10.015_bb0115","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/01.mjt.0000132250.95650.85","article-title":"Opioid therapy and immunosuppression: a review","volume":"11","author":"Vallejo","year":"2004","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.jneuroim.2012.10.015_bb0120","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1146\/annurev.immunol.25.022106.141557","article-title":"IL-17 family cytokines and the expanding diversity of effector T cell lineages","volume":"25","author":"Weaver","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2012.10.015_bb0125","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/ni1488","article-title":"IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways","volume":"8","author":"Zhou","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2012.10.015_bb0130","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.humimm.2008.07.014","article-title":"The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation","volume":"69","author":"Zozulya","year":"2008","journal-title":"Hum. Immunol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572812003189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572812003189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:19:43Z","timestamp":1759047583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572812003189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":26,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0165572812003189"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2012.10.015","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methadone diminishes neuroinflammation and disease severity in EAE through modulating T cell function","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2012.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}